Researchers are making strides in improving gene therapies for genetic diseases, particularly chronic kidney disease, using adeno-associated virus, or AAV, vectors. While AAV-based treatments have shown promise, delivering these therapies effectively to the kidneys has remained a challenge—until now.
There are many different types of AAV capsids—the protein shells of virus particles—that have been used to deliver genes to cells, each with unique effects...
Read More
Recent Comments